| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1660* | 2020 |
| Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition M Sciacovelli, E Gonçalves, TI Johnson, VR Zecchini, ASH Da Costa, ... Nature 537 (7621), 544-547, 2016 | 517 | 2016 |
| Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue CS Cooper, R Eeles, DC Wedge, P Van Loo, G Gundem, LB Alexandrov, ... Nature genetics 47 (4), 367-372, 2015 | 469 | 2015 |
| Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer MKH Hong, G Macintyre, DC Wedge, P Van Loo, K Patel, S Lunke, ... Nature communications 6 (1), 6605, 2015 | 395 | 2015 |
| Integration of copy number and transcriptomics provides risk stratification in prostate cancer: a discovery and validation cohort study H Ross-Adams, AD Lamb, MJ Dunning, S Halim, J Lindberg, CM Massie, ... EBioMedicine 2 (9), 1133-1144, 2015 | 283 | 2015 |
| Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development K Halkidou, VJ Gnanapragasam, PB Mehta, IR Logan, ME Brady, S Cook, ... Oncogene 22 (16), 2466-2477, 2003 | 278 | 2003 |
| Mutational signatures of ionizing radiation in second malignancies S Behjati, G Gundem, DC Wedge, ND Roberts, PS Tarpey, SL Cooke, ... Nature communications 7 (1), 1-8, 2016 | 261 | 2016 |
| Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer VJ Gnanapragasam, HY Leung, AS Pulimood, DE Neal, CN Robson British journal of cancer 85 (12), 1928-1936, 2001 | 240 | 2001 |
| Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets DC Wedge, G Gundem, T Mitchell, DJ Woodcock, I Martincorena, M Ghori, ... Nature genetics 50 (5), 682-692, 2018 | 232 | 2018 |
| Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer FC Hamdy, JL Donovan, JA Lane, C Metcalfe, M Davis, EL Turner, ... New England Journal of Medicine 388 (17), 1547-1558, 2023 | 217 | 2023 |
| Extensive heterogeneity in somatic mutation and selection in the human bladder ARJ Lawson, F Abascal, THH Coorens, Y Hooks, L O’Neill, C Latimer, ... Science 370 (6512), 75-82, 2020 | 215 | 2020 |
| Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI‐transrectal ultrasonography (TRUS) fusion‐guided transperineal … G Gaziev, K Wadhwa, T Barrett, BC Koo, FA Gallagher, E Serrao, J Frey, ... BJU international 117 (1), 80-86, 2016 | 187 | 2016 |
| Active surveillance for prostate cancer: a narrative review of clinical guidelines SM Bruinsma, CH Bangma, PR Carroll, MS Leapman, A Rannikko, ... Nature Reviews Urology 13 (3), 151-167, 2016 | 177 | 2016 |
| Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics. TH Kuru, K Wadhwa, RTM Chang, LMC Echeverria, M Roethke, A Polson, ... BJU international 112 (5), 2013 | 163 | 2013 |
| Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer AB McKie, DA Douglas, S Olijslagers, J Graham, MM Omar, R Heer, ... Oncogene 24 (13), 2166-2174, 2005 | 147 | 2005 |
| Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium CN Robson, V Gnanapragasam, RL Byrne, AT Collins, DE Neal J Endocrinol 160 (2), 257-266, 1999 | 145 | 1999 |
| Selective over‐expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer K Sahadevan, S Darby, HY Leung, ME Mathers, CN Robson, ... The Journal of pathology 213 (1), 82-90, 2007 | 142 | 2007 |
| Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to … DE Neal, C Metcalfe, JL Donovan, JA Lane, M Davis, GJ Young, ... European urology 77 (3), 320-330, 2020 | 140 | 2020 |
| Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity AW Nelson, AJ Groen, JL Miller, AY Warren, KA Holmes, GA Tarulli, ... Molecular and cellular endocrinology 440, 138-150, 2017 | 126 | 2017 |
| One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum C Fernández-Sánchez, CJ McNeil, K Rawson, O Nilsson, HY Leung, ... Journal of Immunological Methods 307 (1-2), 1-12, 2005 | 119 | 2005 |
